Impact Factor
4.51
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
7.13
4,673 total citations
h5-index
69
h5 depth signal
Cited share
89.3%
635 of 711
Total citations
4,673
Citation footprint
Metric signal
6.89
External metric anchor
Self-citation
4.8%
225 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
3,074
United States
299
South Korea
177
Saudi Arabia
170
Italy
129
Citing Fields of Research
Anesthetic & Pain Medicine
774
Phytochemicals
482
Drug Delivery Systems
402
Pharmacology & Toxicology
348
Cancer, Autophagy & Apoptosis
330
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
6,009
Articles tracked across the journal lifetime
Indexed publication set
711
635 cited publications
Last 12 months
963
80.3 publications/month
Open access share
100.0%
963 OA publications in the last year
Leading citing country
China
3,074 citing publications
Leading citing field
Anesthetic & Pain Medicine
774 citing publications
Latest tracked publication
1 October 2026
10 recent records available
Coverage & Indexing History
v1, 2007-
v1, 2007-
Active Coverage
Research Focus & Classification
Indexed Subjects
Anesthetic & Pain Medicine
Broad Categories
Drug Therapy
Pharmacology
Anesthetic & Pain Medicine
Phytochemicals
Respiratory Support
Cancer, Autophagy & Apoptosis
Musculoskeletal Disorders
Cardiology
MeSH Descriptors
Drug Design
Drug Therapy
Pharmaceutical Preparations
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
03
04
DOI 10.2147/dddt.s659416
Open DOI
Everolimus for Tinnitus: A Questionable Causal Chain [Letter]
05
06
DOI 10.2147/dddt.s652340
Open DOI
Efficacy and Safety of Clobazam as Adjunctive Therapy for Pediatric Patients with Refractory Epilepsy in Xinjiang, China: A Multicenter Real-World Study
Objective: This real-world retrospective observational study evaluated the efficacy and safety of clobazam as adjunctive therapy in pediatric patients with refractory epilepsy (RE) in Xinjiang to provide evidence for its rational clinica...
07
DOI 10.2147/dddt.s634756
Open DOI
Optimization of Anticoagulation Strategy During Cardiopulmonary Bypass in Neonates with Congenital Heart Disease: A Randomized Controlled Trial
Purpose: Neonatal hemostatic immaturity complicates anticoagulation during cardiopulmonary bypass (CPB). Current practice largely follows the strategy of 400 U/kg from adult protocols, as neonatal-specific guidelines and high-quality evi...
08
DOI 10.2147/dddt.s630414
Open DOI
Application of Machine Learning Models to Predict Tigecycline Exposure in Critically Ill Patients Using Different Limited Sampling Strategies
Background: The high variability in the pharmacokinetics of tigecycline may impact therapeutic efficacy, particularly in critically ill patients. This study introduces machine learning (ML) methods, aiming to clarify their effectiveness ...
09
DOI 10.2147/dddt.s631934
Open DOI
Epigenetic Regulatory Networks in Cardiac Fibrosis: Therapeutic Targets, Crosstalk, and Future Directions
Cardiac fibrosis is a central driver of pathological cardiac remodeling and a critical risk factor for the progression to heart failure. Cardiac fibrosis may induce myocardial ischemia and hypoxia, impaired cardiac function, and arrhythm...
10
DOI 10.2147/dddt.s630545
Open DOI
Effect of a Subanesthetic Dose of Esketamine on Postoperative Sleep Disturbance After Oocyte Retrieval Under Intravenous Anesthesia: A Randomized Controlled Trial
Purpose: Postoperative sleep disturbance (PSD) is a common complication after oocyte retrieval under intravenous anesthesia. This study aimed to evaluate whether a subanesthetic dose of esketamine reduces the incidence of PSD. Patients a...
Bibliographical & Catalog Notes
Description based on first issue; title from journal homepage (publisher's Web site, viewed June 18, 2008).
Latest issue consulted: 2008 (viewed June 18, 2008).